Statement Of Changes In Equity [Abstract]

Medistim - Filing #2583905

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
367 691 NOK
16 797 NOK
41 852 NOK
285 736 NOK
21,000 NOK
4 585 NOK
65 158 NOK
302 533 NOK
18 742 NOK
26,000 NOK
240 160 NOK
6 138 NOK
13 344 NOK
306 052 NOK
246 298 NOK
59 754 NOK
41 852 NOK
4 585 NOK
203 899 NOK
5 762 NOK
52 165 NOK
4 585 NOK
204 680 NOK
33,000 NOK
781,000 NOK
41 852 NOK
256 845 NOK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
113 973 NOK
90 900 NOK
Comprehensive income
- NOK
- NOK
10 659 NOK
124 632 NOK
113 973 NOK
124 632 NOK
- NOK
- NOK
- NOK
96 257 NOK
- NOK
- NOK
5 357 NOK
- NOK
- NOK
- NOK
96 257 NOK
90 900 NOK
Dividends recognised as distributions to owners
- NOK
- NOK
- NOK
68 396 NOK
68 396 NOK
68 396 NOK
- NOK
- NOK
- NOK
54 640 NOK
- NOK
- NOK
- NOK
- NOK
- NOK
- NOK
54 640 NOK
54 640 NOK
Increase (decrease) through share-based payment transactions, equity
6,000 NOK
- NOK
- NOK
5 404 NOK
- NOK
- NOK
5 404 NOK
- NOK
5 398 NOK
- NOK
7 589 NOK
7,000 NOK
- NOK
- NOK
- NOK
7 582 NOK
7 589 NOK
- NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.